Remarkably, in this unbiased analysis, four clinical markers used in liver disease—ALT, AST, ALP, and GGT—clustered into a single group together with a panel of five proteins of special interest—PIGR, DPP4, ANPEP, TGFBI, and APOE. This evidence concerns the gene GPT and liver disorder.